Can a common parasite drug boost cancer immunotherapy?
NCT ID NCT07487805
First seen Apr 08, 2026 · Last updated May 09, 2026 · Updated 2 times
Summary
This study looks at whether adding ivermectin, a drug used for parasites, to standard immunotherapy can safely help the immune system fight solid tumors. About 80 adults already on immunotherapy will take ivermectin pills for two weeks. Researchers will check for side effects and measure immune cell changes in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.